Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES02 - Management of Lung Cancer in the Era of COVID-19 I
- 10:45 - 11:45
- 8/07/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Management of Lung Cancer in the Era of COVID-19
- Moderators:Marina Chiara Garassino, Christian Grohe
-
+
Session Moderator
10:59 - 11:11 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
Session Moderator
10:59 - 11:11 | Presenter: Christian Grohe
- Abstract
Loading... -
+
ES02.01 - Session Introduction
10:45 - 10:46 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
ES02.02 - Session Introduction
10:46 - 10:47 | Presenter: Christian Grohe
- Abstract
Loading... -
+
ES02.03 - Impact of the COVID-19 Pandemic on Lung Cancer Diagnosis and Screening
10:47 - 10:59 | Presenter: Betty Tong
- Abstract
Loading... -
+
ES02.04 - Impact of the COVID-19 Pandemic on Surgery
10:59 - 11:11 | Presenter: Leanne Ashrafian
- Abstract
Loading... -
+
ES02.05 - Impact of the COVID-19 Pandemic on Radiotherapy
11:11 - 11:23 | Presenter: Umberto Ricardi
- Abstract
Loading... -
+
ES02.06 - Impact of the COVID-19 Pandemic on Systemic Treatment
11:23 - 11:35 | Presenter: Wilfried Ernst Erich Eberhardt
- Abstract
Loading... -
+
ES02.07 - Live Q&A
11:35 - 11:45
- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- 14:30 - 15:40
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Andrew Ciupek, David R. Gandara
-
+
OA03.05 - Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C
14:52 - 15:02 | Presenter: Michael Thomas
- Abstract
Loading...
-
+
EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
-
+
EP07.01-021 - Clinical and Biochemical Profiling of Pleural Mesothelioma Patients Treated With Immunotherapy
Presenter: Sara Manglaviti- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-006 - Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy
Presenter: Alessandro De Toma- Abstract
Loading... -
+
EP08.01-020 - Phase 2 Platform Trial of Anti-TIGIT GSK’859A/EOS-448 + Anti-PD-1 Dostarlimab in Non-small Cell Lung Cancer (NSCLC)
Presenter: David Spigel- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-108 - Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
Presenter: Marina Chiara Garassino- Abstract
Loading...
-
+
P1.15 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
P1.15-02 - Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors
Presenter: Claudia Proto- Abstract
Loading...
-
+
P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
P1.16-04 - Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors
Presenter: Niels Reinmuth- Abstract
Loading...
-
+
OA06 - Impact of COVID-19 on Cancer Management and Protection from Vaccines
- 11:00 - 12:10
- 8/08/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Moderators:Marina Chiara Garassino, Christian Grohe
-
+
Session Moderator
11:42 - 11:52 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
Session Moderator
11:42 - 11:52 | Presenter: Christian Grohe
- Abstract
Loading... -
+
OA06.01 - Session Introduction
11:00 - 11:01 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
OA06.02 - Session Introduction
11:01 - 11:02 | Presenter: Christian Grohe
- Abstract
Loading... -
+
OA06.03 - Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study
11:02 - 11:12 | Presenter: Philip C Mack
- Abstract
Loading... -
+
OA06.04 - Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort
11:12 - 11:22 | Presenter: Ainhoa Hernandez
- Abstract
Loading... -
+
OA06.05 - Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands
11:22 - 11:32 | Presenter: Nienke Wolfhagen
- Abstract
Loading... -
+
OA06.06 - Impact of Systemic Anti-cancer Treatments on Outcomes of COVID-19 in Patients with Thoracic Cancers: CCC19 Registry Analysis
11:32 - 11:42 | Presenter: Amit Kulkarni
- Abstract
Loading... -
+
OA06.07 - Stereotactic Ablative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts
11:42 - 11:52 | Presenter: Biniam Kidane
- Abstract
Loading... -
+
OA06.08 - Discussant
11:52 - 12:02 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
OA06.09 - Live Q&A
12:02 - 12:10
- Abstract
Loading...
-
+
MA10 - Updates in Thymoma
- 14:45 - 15:45
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Moderators:Noboru Yamamoto, Paul J Van Houtte
-
+
MA10.07 - Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)
15:12 - 15:17 | Presenter: Claudia Proto
- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- 14:30 - 15:30
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Pilar Garrido, António Araújo
-
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Presenter: Delvys Rodriguez-Abreu
- Abstract
Loading...
